ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 1 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,567,000 | -2.7% | 206,352 | +7.1% | 0.01% | 0.0% |
Q3 2016 | $2,639,000 | +89.4% | 192,738 | +2.2% | 0.01% | +75.0% |
Q2 2016 | $1,393,000 | +25.4% | 188,563 | +8.4% | 0.00% | +33.3% |
Q1 2016 | $1,111,000 | +2.0% | 173,888 | -0.2% | 0.00% | -25.0% |
Q4 2015 | $1,089,000 | +15.4% | 174,193 | +7.8% | 0.00% | +33.3% |
Q3 2015 | $944,000 | -28.0% | 161,633 | +1.9% | 0.00% | -25.0% |
Q2 2015 | $1,312,000 | -2.5% | 158,638 | -2.8% | 0.00% | 0.0% |
Q1 2015 | $1,345,000 | +42.8% | 163,263 | +19.0% | 0.00% | +33.3% |
Q4 2014 | $942,000 | +22.5% | 137,188 | -3.7% | 0.00% | +50.0% |
Q3 2014 | $769,000 | -14.9% | 142,406 | +0.3% | 0.00% | -33.3% |
Q2 2014 | $904,000 | -21.9% | 141,986 | -1.1% | 0.00% | 0.0% |
Q1 2014 | $1,157,000 | +12.5% | 143,512 | -4.8% | 0.00% | 0.0% |
Q4 2013 | $1,028,000 | -66.7% | 150,749 | -10.1% | 0.00% | -70.0% |
Q3 2013 | $3,084,000 | +2.9% | 167,622 | -2.2% | 0.01% | 0.0% |
Q2 2013 | $2,997,000 | – | 171,370 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,331,100 | $23,281,000 | 8.28% |
DAFNA Capital Management LLC | 191,215 | $3,344,000 | 4.89% |
Redmile Group, LLC | 1,277,109 | $22,337,000 | 3.94% |
BB BIOTECH AG | 3,115,371 | $54,488,000 | 3.92% |
SECTORAL ASSET MANAGEMENT INC | 5,292,682 | $92,569,000 | 2.74% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 565,956 | $9,899,000 | 1.76% |
OAK RIDGE INVESTMENTS LLC | 2,645,781 | $46,275,000 | 1.45% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,104 | $22,127,000 | 1.04% |
Tekla Capital Management LLC | 412,965 | $7,223,000 | 0.98% |
Private Capital Advisors, Inc. | 127,600 | $2,232,000 | 0.83% |